Rod Quilitz, Pharm.D., BCOP
Friday, February 7, 2014
Category: Antimicrobial Stewardship, Immunocompromised Host, Infectious in Oncology, Mould Infections
Friday, February 7, 2014
Category: Antimicrobial Stewardship, Immunocompromised Host, Infectious in Oncology, Mould Infections
Length:
Rod Quilitz, PharmD, speaks about the conscientious use of antimicrobials in cancer patients. Cancer patients have increased risk of infections due to circumstances like neutropenia, indwelling chemotherapy catheters, breakdown of epithelium from chemotherapy, and immunosuppression. They are at risk for infections from multidrug resistant organisms as they spend more and more time in healthcare facilities. As such, Dr. Quilitz covers his experience with antimicrobial stewardship at Moffitt Cancer Center, and some guidelines on the management of infections in cancer patients.
Stay in touch! Download our app in the iTunes store or the Google Marketplace.
